Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037036 · ClinicalTrials.gov registry record · Phase 2
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
A Phase 2 study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01037036 is a Phase 2 study that has completed, run by Mati Therapeutics. The registered enrollment target is 15 participants.
The verdict
NCT01037036, a Phase 2 study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.
Interventions
- DRUG Xalatan
- DRUG Latanoprost Punctal Plug Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037036
The ClinicalTrials.gov registry entry for NCT01037036 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mati Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Xalatan is the first listed.
NCT01037036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037036 about?
NCT01037036 is a clinical study titled "A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG". The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.
What is the current status of trial NCT01037036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01037036?
The interventions under investigation include: Xalatan (DRUG), Latanoprost Punctal Plug Delivery System (DRUG).
Who is sponsoring clinical trial NCT01037036?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.